We have located links that may give you full text access.
Survival of colorectal cancer in Iran.
Asian Pacific Journal of Cancer Prevention : APJCP 2009 October
OBJECTIVE: Colorectal cancer is the fourth cause of cancer after stomach, bladder, prostate in men and second cause after breast in women in Iran. It is estimated that 4,000 new cases occur each year with 1,150 deaths annually. The present study aimed to determine survival of colorectal cancers in Iran in a national manner.
METHODS AND RESULTS: The data from national cancer registry department of the Ministry of Health and Medical Education (MOH and ME) were used as the main source of incident colorectal cancer information in Iran from March 2000 to March 2005. One and five year survival proportions were 88% and 45% for females versus 86% and 39% for men. The median overall survival for colorectal cancer in Iran was 3.5 years with a 95 % confidence interval of 3.2-3.8 years. The worst survival status was found for patients less than 20 and more than 80 years old.
CONCLUSION: The overall 5 year survival for colorectal cancer in Iran (41%) is comparable even with some developed countries but it is far from those with advanced health care systems, or community based screening programs. Thus at the policy level, application of an appropriate national cancer control program and management guidelines should be under consideration.
METHODS AND RESULTS: The data from national cancer registry department of the Ministry of Health and Medical Education (MOH and ME) were used as the main source of incident colorectal cancer information in Iran from March 2000 to March 2005. One and five year survival proportions were 88% and 45% for females versus 86% and 39% for men. The median overall survival for colorectal cancer in Iran was 3.5 years with a 95 % confidence interval of 3.2-3.8 years. The worst survival status was found for patients less than 20 and more than 80 years old.
CONCLUSION: The overall 5 year survival for colorectal cancer in Iran (41%) is comparable even with some developed countries but it is far from those with advanced health care systems, or community based screening programs. Thus at the policy level, application of an appropriate national cancer control program and management guidelines should be under consideration.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app